through miR-132 and miR-26a Responsiveness γ Human Macrophage IFN- Decreases Mycobacterium tuberculosis
暂无分享,去创建一个
[1] S. Dhandayuthapani,et al. Differential expression of miRNAs by macrophages infected with virulent and avirulent Mycobacterium tuberculosis. , 2013, Tuberculosis.
[2] J. Schreiber,et al. MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. , 2013, The Journal of clinical investigation.
[3] Fei Zhai,et al. miR-582-5p Is Upregulated in Patients with Active Tuberculosis and Inhibits Apoptosis of Monocytes by Targeting FOXO1 , 2013, PloS one.
[4] D. Chauhan,et al. Current understanding on micro RNAs and its regulation in response to Mycobacterial infections , 2013, Journal of Biomedical Science.
[5] Leon N. Schulte,et al. The mammalian microRNA response to bacterial infections , 2012, RNA biology.
[6] S. Gagneux. Host–pathogen coevolution in human tuberculosis , 2012, Philosophical Transactions of the Royal Society B: Biological Sciences.
[7] Murugesan V. S. Rajaram,et al. Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b , 2011, Proceedings of the National Academy of Sciences.
[8] Xiongfei Xu,et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ , 2011, Nature Immunology.
[9] Xinjing Wang,et al. Modulation of T cell cytokine production by miR-144* with elevated expression in patients with pulmonary tuberculosis. , 2011, Molecular immunology.
[10] S. Gordon,et al. Innate immunity to intracellular pathogens: macrophage receptors and responses to microbial entry , 2011, Immunological reviews.
[11] Murugesan V. S. Rajaram,et al. NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages , 2011, Cellular microbiology.
[12] Murugesan V. S. Rajaram,et al. Mycobacterium tuberculosis Activates Human Macrophage Peroxisome Proliferator-Activated Receptor γ Linking Mannose Receptor Recognition to Regulation of Immune Responses , 2010, The Journal of Immunology.
[13] Frances Gotch,et al. miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator , 2010, Nature Cell Biology.
[14] V. Lafont,et al. The IFNgamma-induced STAT1-CBP/P300 association, required for a normal response to the cytokine, is disrupted in Brucella-infected macrophages. , 2009, Microbial pathogenesis.
[15] S. Snyder,et al. Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis , 2008, Nature Cell Biology.
[16] A. Azad,et al. Pulmonary surfactant protein A regulates TLR expression and activity in human macrophages. , 2008, Journal of immunology.
[17] A. Azad,et al. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis , 2005, The Journal of experimental medicine.
[18] L. Platanias. Mechanisms of type-I- and type-II-interferon-mediated signalling , 2005, Nature Reviews Immunology.
[19] Michael C. Ostrowski,et al. The Serine/Threonine Kinase Akt Promotes Fcγ Receptor-mediated Phagocytosis in Murine Macrophages through the Activation of p70S6 Kinase* , 2004, Journal of Biological Chemistry.
[20] Z. Darieva,et al. Activation of phosphatidylinositol 3‐kinase and c‐Jun‐N‐terminal kinase cascades enhances NF‐κB‐dependent gene transcription in BCG‐stimulated macrophages through promotion of p65/p300 binding , 2004, Journal of leukocyte biology.
[21] K. Schroder,et al. Interferon- : an overview of signals, mechanisms and functions , 2004 .
[22] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[23] Chilakamarti V. Ramana,et al. Stat1-dependent and -independent pathways in IFN-γ-dependent signaling , 2002 .
[24] S. Roy,et al. ERK1 and ERK2 Activate CCAAAT/Enhancer-binding Protein-β-dependent Gene Transcription in Response to Interferon-γ* , 2001, The Journal of Biological Chemistry.
[25] L. Ting,et al. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. , 1999, Journal of immunology.
[26] S. Dorman,et al. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. , 1998, The Journal of clinical investigation.
[27] M. Fenton. Macrophages and tuberculosis , 1998, Current opinion in hematology.
[28] J. Casanova,et al. Infections in IFNGR-1-deficient children. , 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[29] M. Newport,et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. , 1996, The New England journal of medicine.
[30] J. Flynn,et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.
[31] L. Schlesinger. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. , 1993, Journal of immunology.
[32] M. Horwitz,et al. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. , 1990, Journal of immunology.
[33] Á. Ruibal,et al. High level of interferon gamma in tuberculous pleural effusion. , 1988, Chest.
[34] B. Champion,et al. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. , 1986, Immunology.
[35] M. Horwitz,et al. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. , 1980, The Journal of clinical investigation.